"CITYWIDE - NYU LANGONE HEALTH HAS APPOINTED DR. ANIRBAN MAITRA, a leader in gastrointestinal oncology, as the new director of its Laura and Isaac Perlmutter Cancer Center, an NCI-designated Comprehensive Cancer Center. Dr. Maitra is a preeminent physician-scientist whose work has widely influenced the field of pancreatic cancer research. As the inaugural scientific director of the Pancreatic Cancer Research Center at the University of Texas MD Anderson Cancer Center in Houston, Dr. Maitra focused his work on early detection and biomarker development, considered two key avenues for effective cancer treatments."
"He also held a number of leadership roles at MD Anderson, before being named co-director of NYU Langone's Gastrointestinal (GI) Cancer Center, which cares for patients with GI cancer or precancerous conditions. Dr. Maitra also previously served as associate director of translational research, where he led efforts to drive discovery from the lab to patient care in the clinic. The Perlmutter Cancer Center treats patients at several locations in Manhattan, Brooklyn, and Queens and on Long Island."
Dr. Anirban Maitra has been appointed director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health. He is a preeminent physician-scientist with major influence in pancreatic cancer research. He served as the inaugural scientific director of the Pancreatic Cancer Research Center at MD Anderson, focusing on early detection and biomarker development. He held multiple leadership roles at MD Anderson before becoming co-director of NYU Langone's Gastrointestinal Cancer Center. He previously served as associate director of translational research, leading efforts to translate lab discoveries to clinical care. The Perlmutter Cancer Center treats patients across Manhattan, Brooklyn, Queens, and Long Island.
Read at Brooklyn Eagle
Unable to calculate read time
Collection
[
|
...
]